Skip to main content

Navalign, LLC

SEC CIK
0001820593
Latest filing
Jul 27, 2026

Holdings in Q2 2024

Holdings as of Jun 30, 2024, filed Jul 30, 2024. Long positions only; changes compare share counts with Q1 2024.

Institution overview
Positions
115
−1 vs. Q1 2024
Portfolio value
$316.8M
+$15.0M (+5.0%) vs. Q1 2024
Filed
Jul 30, 2024
SEC
Holdings of Navalign, LLC in Q2 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
iShares S&P 500 Growth ETF464287309ETF3,422$316.7K0.1%−4−0.1%Reduced–
BCALCalifornia BanCorpCOM22,800$307.1K0.1%00.0%UnchangedHistory
SPDR Series Trust78464A201ST STR SP600GRWO3,569$306.4K0.1%−1,171−24.7%Reduced–
iShares Tr46434V860TRS FLT RT BD5,550$281.2K0.1%00.0%Unchanged–
ABTAbbott LaboratoriesStock2,622$272.5K0.1%−90−3.3%ReducedHistory
PAYXPaychex IncStock2,289$271.4K0.1%00.0%UnchangedHistory
iShares Tr464288521CRE U S REIT ETF4,210$225.5K0.1%+4,210New–
LOWLowes Companies IncStock1,014$223.6K0.1%00.0%UnchangedHistory
AZNAstraZeneca PLCSPONSORED ADR2,625$204.7K0.1%+2,625NewHistory
Goldman Sachs ETF Tr381430230ULTR SHOR BD ETF4,049$203.9K0.1%−705−14.8%Reduced–
Invesco QQQ Trust Series I46090E103ETF425$203.4K0.1%+425New–
SYKStryker CorpStock590$200.7K0.1%00.0%UnchangedHistory
XOMExxonMobil Holdings CorpCOM1,739$200.2K0.1%+1,739NewHistory
ALLOAllogene Therapeutics, Inc.COM75,365$175.6K0.1%00.0%UnchangedHistory
CUECue Biopharma, Inc.COM25,000$31.0K<0.1%00.0%UnchangedHistory

Sold out since Q1 2024 (5)

Positions held at the end of Q1 2024 that are gone from this filing.

Positions of Navalign, LLC sold out since Q1 2024
SecurityClassShares in Q1 2024Value in Q1 2024% of portfolio in Q1 2024History
Fidelity Covington Trust316092790QLTY FCTOR ETF5,632$332.0K0.1%–
Vanguard Morningstar Mid-Cap Value ETF922908512ETF1,785$278.4K0.1%–
DISWalt Disney CoStock1,932$236.4K0.1%History
J P Morgan Exchange Traded F46641Q332EQUITY PREMIUM3,550$205.4K0.1%–
PLPlanet Labs PBCCOM CL A11,168$28.5K<0.1%History